Review



rabbit polyclonal anti-e2f5  (Thermo Fisher)


Bioz Verified Symbol Thermo Fisher is a verified supplier
Bioz Manufacturer Symbol Thermo Fisher manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Thermo Fisher rabbit polyclonal anti-e2f5
    (A) Normalized expression of <t>E2F5</t> in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Rabbit Polyclonal Anti E2f5, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-e2f5/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-e2f5 - by Bioz Stars, 2026-06
    90/100 stars

    Images

    1) Product Images from "Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy"

    Article Title: Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy

    Journal: bioRxiv

    doi: 10.1101/2024.11.27.625731

    (A) Normalized expression of E2F5 in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Figure Legend Snippet: (A) Normalized expression of E2F5 in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.

    Techniques Used: Expressing, Isolation, Labeling

    Paired mammary wholemounts (A) and H&E staining (B) from 12 weeks virgin adult E2F5 CKO, day 5 pregnant E2F5 f/f and day 5 pregnant E2F5 CKO mice shown an impairment on alveoli formation during pregnancy on mice lacking E2F5 in mammary epithelium. (C) PCNA expression in pregnant mice shows reduced proliferative activity in E2F5 CKO mice. (D) Alveoli quantification shown reduced proliferative activity in mice lacking E2F5 in mammary epithelium (p=0.0025).
    Figure Legend Snippet: Paired mammary wholemounts (A) and H&E staining (B) from 12 weeks virgin adult E2F5 CKO, day 5 pregnant E2F5 f/f and day 5 pregnant E2F5 CKO mice shown an impairment on alveoli formation during pregnancy on mice lacking E2F5 in mammary epithelium. (C) PCNA expression in pregnant mice shows reduced proliferative activity in E2F5 CKO mice. (D) Alveoli quantification shown reduced proliferative activity in mice lacking E2F5 in mammary epithelium (p=0.0025).

    Techniques Used: Staining, Expressing, Activity Assay

    (A) Early pregnancy in E2F5 CKO females undergoing a second gestation shows reduced number of alveoli in comparison with E2F5 f/f group. Upon day 14 of pregnancy, E2F5 CKO females shows non phenotypic differences in comparison with control groups. (B) Matched histological sections shown evidence of early but no late pregnancy defects in E2F5 CKO females.
    Figure Legend Snippet: (A) Early pregnancy in E2F5 CKO females undergoing a second gestation shows reduced number of alveoli in comparison with E2F5 f/f group. Upon day 14 of pregnancy, E2F5 CKO females shows non phenotypic differences in comparison with control groups. (B) Matched histological sections shown evidence of early but no late pregnancy defects in E2F5 CKO females.

    Techniques Used: Comparison, Control

    (A) Principal component analysis (PCA) plot showing clustering of CUT&RUN data based on chromatin occupancy for E2F5, H3K4me3, H3K27me3, and IgG across two replicates each. (B) De novo motif discovery using MEME-ChIP revealed a motif that is distinct from the known E2F consensus motif. (C) Motif similarity analysis using Tomtom identified overlap between the discovered E2F5 motif and the known E2F consensus motif. (D) Integrative Genomics Viewer (IGV) tracks showing E2F5 and H3K4me3 occupancy at the promoters of known cell cycle regulatory genes, including CDKN2A, CDKN2B, CDKN2C, CDK4, and CCND1, supporting the role of E2F5 in regulating genes involved in cellular proliferation.
    Figure Legend Snippet: (A) Principal component analysis (PCA) plot showing clustering of CUT&RUN data based on chromatin occupancy for E2F5, H3K4me3, H3K27me3, and IgG across two replicates each. (B) De novo motif discovery using MEME-ChIP revealed a motif that is distinct from the known E2F consensus motif. (C) Motif similarity analysis using Tomtom identified overlap between the discovered E2F5 motif and the known E2F consensus motif. (D) Integrative Genomics Viewer (IGV) tracks showing E2F5 and H3K4me3 occupancy at the promoters of known cell cycle regulatory genes, including CDKN2A, CDKN2B, CDKN2C, CDK4, and CCND1, supporting the role of E2F5 in regulating genes involved in cellular proliferation.

    Techniques Used:

    (A) Integrative Genomics Viewer (IGV) tracks showing E2F5, H3K4me3, and IgG CUT&RUN signal at the STAT6 promoter in HC11 mouse mammary epithelial cells. (B) Luciferase reporter assay in 293T cells showing that E2F5 represses STAT6 promoter activity. (C) STAT6 promoter-luciferase reporter assay of MCF7 cells treated with vehicle or R5020 and co-transfected with CMV-HA-E2F5 or CMV-Neo-Bam (empty vector).
    Figure Legend Snippet: (A) Integrative Genomics Viewer (IGV) tracks showing E2F5, H3K4me3, and IgG CUT&RUN signal at the STAT6 promoter in HC11 mouse mammary epithelial cells. (B) Luciferase reporter assay in 293T cells showing that E2F5 represses STAT6 promoter activity. (C) STAT6 promoter-luciferase reporter assay of MCF7 cells treated with vehicle or R5020 and co-transfected with CMV-HA-E2F5 or CMV-Neo-Bam (empty vector).

    Techniques Used: Luciferase, Reporter Assay, Activity Assay, Transfection, Plasmid Preparation

    In the absence of progesterone signaling, E2F5 binds to the STAT6 promoter and represses its transcription (left panel). Upon activation of PR, E2F5-mediated repression is relieved, leading to transcriptional activation of STAT6. This could occur either by displacement of E2F5 from the STAT6 promoter or through cooperation between E2F5 and activated PR at the STAT6 promoter (right panel).
    Figure Legend Snippet: In the absence of progesterone signaling, E2F5 binds to the STAT6 promoter and represses its transcription (left panel). Upon activation of PR, E2F5-mediated repression is relieved, leading to transcriptional activation of STAT6. This could occur either by displacement of E2F5 from the STAT6 promoter or through cooperation between E2F5 and activated PR at the STAT6 promoter (right panel).

    Techniques Used: Activation Assay



    Similar Products

    93
    Bioss rabbit anti e2f5
    Rabbit Anti E2f5, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti e2f5/product/Bioss
    Average 93 stars, based on 1 article reviews
    rabbit anti e2f5 - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    Thermo Fisher rabbit polyclonal anti-e2f5
    (A) Normalized expression of <t>E2F5</t> in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Rabbit Polyclonal Anti E2f5, supplied by Thermo Fisher, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-e2f5/product/Thermo Fisher
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-e2f5 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    99
    Abcam rabbit polyclonal antibody anti e2f5
    (A) Normalized expression of <t>E2F5</t> in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Rabbit Polyclonal Antibody Anti E2f5, supplied by Abcam, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal antibody anti e2f5/product/Abcam
    Average 99 stars, based on 1 article reviews
    rabbit polyclonal antibody anti e2f5 - by Bioz Stars, 2026-06
    99/100 stars
      Buy from Supplier

    93
    Bioss rabbit anti c e2f5 polyclonal antibody
    (A) Normalized expression of <t>E2F5</t> in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Rabbit Anti C E2f5 Polyclonal Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti c e2f5 polyclonal antibody/product/Bioss
    Average 93 stars, based on 1 article reviews
    rabbit anti c e2f5 polyclonal antibody - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    OriGene rabbit anti c e2f5 polyclonal antibody
    (A) Normalized expression of <t>E2F5</t> in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Rabbit Anti C E2f5 Polyclonal Antibody, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit anti c e2f5 polyclonal antibody/product/OriGene
    Average 90 stars, based on 1 article reviews
    rabbit anti c e2f5 polyclonal antibody - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit polyclonal anti-e2f5 antibody
    (A) Normalized expression of <t>E2F5</t> in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Rabbit Polyclonal Anti E2f5 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti-e2f5 antibody/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti-e2f5 antibody - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    93
    Santa Cruz Biotechnology rabbit polyclonal anti e2f5 antibody
    (A) Normalized expression of <t>E2F5</t> in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Rabbit Polyclonal Anti E2f5 Antibody, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti e2f5 antibody/product/Santa Cruz Biotechnology
    Average 93 stars, based on 1 article reviews
    rabbit polyclonal anti e2f5 antibody - by Bioz Stars, 2026-06
    93/100 stars
      Buy from Supplier

    90
    Santa Cruz Biotechnology rabbit polyclonal anti–rat e2f5
    (A) Normalized expression of <t>E2F5</t> in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.
    Rabbit Polyclonal Anti–Rat E2f5, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rabbit polyclonal anti–rat e2f5/product/Santa Cruz Biotechnology
    Average 90 stars, based on 1 article reviews
    rabbit polyclonal anti–rat e2f5 - by Bioz Stars, 2026-06
    90/100 stars
      Buy from Supplier

    Image Search Results


    (A) Normalized expression of E2F5 in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.

    Journal: bioRxiv

    Article Title: Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy

    doi: 10.1101/2024.11.27.625731

    Figure Lengend Snippet: (A) Normalized expression of E2F5 in whole mammary glands at different stages of development: virgin, pregnancy day 6 (P6), pregnancy day 18 (P18), lactation day 1 (L1), and lactation day 10 (L10). (B) Normalized expression of E2F5 in basal and luminal cells isolated from mammary glands at different stages: virgin, pregnancy day 18.5 (Preg day 18.5), and lactation day 2 (Lac day 2). (C) Venn diagram showing overlap between E2f5 CUT&RUN target genes and differentially expressed genes in early pregnancy (virgin vs. P6). (D) Normalized expression of several up-regulated E2f5 target genes known to be associated with proliferation and differentiation during pregnancy. (E) Volcano plot of differentially expressed genes between virgin and P6, with E2f5 targets labeled.

    Article Snippet: For CUT&RUN, rabbit IgG (Epicypher #13-0042; RRID:AB_2923178), rabbit monoclonal anti-H3K27me3 (Invitrogen #MA5-11198; RRID:AB_1100074), rabbit monoclonal anti-H3K4me3 (Epicypher #13-0041; RRID:AB_3076423), and rabbit polyclonal anti-E2F5 (Invitrogen #PA585578; RRID:AB_2792718) were used at 0.5 ug per sample replicate in 50 uL of volume.

    Techniques: Expressing, Isolation, Labeling

    Paired mammary wholemounts (A) and H&E staining (B) from 12 weeks virgin adult E2F5 CKO, day 5 pregnant E2F5 f/f and day 5 pregnant E2F5 CKO mice shown an impairment on alveoli formation during pregnancy on mice lacking E2F5 in mammary epithelium. (C) PCNA expression in pregnant mice shows reduced proliferative activity in E2F5 CKO mice. (D) Alveoli quantification shown reduced proliferative activity in mice lacking E2F5 in mammary epithelium (p=0.0025).

    Journal: bioRxiv

    Article Title: Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy

    doi: 10.1101/2024.11.27.625731

    Figure Lengend Snippet: Paired mammary wholemounts (A) and H&E staining (B) from 12 weeks virgin adult E2F5 CKO, day 5 pregnant E2F5 f/f and day 5 pregnant E2F5 CKO mice shown an impairment on alveoli formation during pregnancy on mice lacking E2F5 in mammary epithelium. (C) PCNA expression in pregnant mice shows reduced proliferative activity in E2F5 CKO mice. (D) Alveoli quantification shown reduced proliferative activity in mice lacking E2F5 in mammary epithelium (p=0.0025).

    Article Snippet: For CUT&RUN, rabbit IgG (Epicypher #13-0042; RRID:AB_2923178), rabbit monoclonal anti-H3K27me3 (Invitrogen #MA5-11198; RRID:AB_1100074), rabbit monoclonal anti-H3K4me3 (Epicypher #13-0041; RRID:AB_3076423), and rabbit polyclonal anti-E2F5 (Invitrogen #PA585578; RRID:AB_2792718) were used at 0.5 ug per sample replicate in 50 uL of volume.

    Techniques: Staining, Expressing, Activity Assay

    (A) Early pregnancy in E2F5 CKO females undergoing a second gestation shows reduced number of alveoli in comparison with E2F5 f/f group. Upon day 14 of pregnancy, E2F5 CKO females shows non phenotypic differences in comparison with control groups. (B) Matched histological sections shown evidence of early but no late pregnancy defects in E2F5 CKO females.

    Journal: bioRxiv

    Article Title: Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy

    doi: 10.1101/2024.11.27.625731

    Figure Lengend Snippet: (A) Early pregnancy in E2F5 CKO females undergoing a second gestation shows reduced number of alveoli in comparison with E2F5 f/f group. Upon day 14 of pregnancy, E2F5 CKO females shows non phenotypic differences in comparison with control groups. (B) Matched histological sections shown evidence of early but no late pregnancy defects in E2F5 CKO females.

    Article Snippet: For CUT&RUN, rabbit IgG (Epicypher #13-0042; RRID:AB_2923178), rabbit monoclonal anti-H3K27me3 (Invitrogen #MA5-11198; RRID:AB_1100074), rabbit monoclonal anti-H3K4me3 (Epicypher #13-0041; RRID:AB_3076423), and rabbit polyclonal anti-E2F5 (Invitrogen #PA585578; RRID:AB_2792718) were used at 0.5 ug per sample replicate in 50 uL of volume.

    Techniques: Comparison, Control

    (A) Principal component analysis (PCA) plot showing clustering of CUT&RUN data based on chromatin occupancy for E2F5, H3K4me3, H3K27me3, and IgG across two replicates each. (B) De novo motif discovery using MEME-ChIP revealed a motif that is distinct from the known E2F consensus motif. (C) Motif similarity analysis using Tomtom identified overlap between the discovered E2F5 motif and the known E2F consensus motif. (D) Integrative Genomics Viewer (IGV) tracks showing E2F5 and H3K4me3 occupancy at the promoters of known cell cycle regulatory genes, including CDKN2A, CDKN2B, CDKN2C, CDK4, and CCND1, supporting the role of E2F5 in regulating genes involved in cellular proliferation.

    Journal: bioRxiv

    Article Title: Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy

    doi: 10.1101/2024.11.27.625731

    Figure Lengend Snippet: (A) Principal component analysis (PCA) plot showing clustering of CUT&RUN data based on chromatin occupancy for E2F5, H3K4me3, H3K27me3, and IgG across two replicates each. (B) De novo motif discovery using MEME-ChIP revealed a motif that is distinct from the known E2F consensus motif. (C) Motif similarity analysis using Tomtom identified overlap between the discovered E2F5 motif and the known E2F consensus motif. (D) Integrative Genomics Viewer (IGV) tracks showing E2F5 and H3K4me3 occupancy at the promoters of known cell cycle regulatory genes, including CDKN2A, CDKN2B, CDKN2C, CDK4, and CCND1, supporting the role of E2F5 in regulating genes involved in cellular proliferation.

    Article Snippet: For CUT&RUN, rabbit IgG (Epicypher #13-0042; RRID:AB_2923178), rabbit monoclonal anti-H3K27me3 (Invitrogen #MA5-11198; RRID:AB_1100074), rabbit monoclonal anti-H3K4me3 (Epicypher #13-0041; RRID:AB_3076423), and rabbit polyclonal anti-E2F5 (Invitrogen #PA585578; RRID:AB_2792718) were used at 0.5 ug per sample replicate in 50 uL of volume.

    Techniques:

    (A) Integrative Genomics Viewer (IGV) tracks showing E2F5, H3K4me3, and IgG CUT&RUN signal at the STAT6 promoter in HC11 mouse mammary epithelial cells. (B) Luciferase reporter assay in 293T cells showing that E2F5 represses STAT6 promoter activity. (C) STAT6 promoter-luciferase reporter assay of MCF7 cells treated with vehicle or R5020 and co-transfected with CMV-HA-E2F5 or CMV-Neo-Bam (empty vector).

    Journal: bioRxiv

    Article Title: Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy

    doi: 10.1101/2024.11.27.625731

    Figure Lengend Snippet: (A) Integrative Genomics Viewer (IGV) tracks showing E2F5, H3K4me3, and IgG CUT&RUN signal at the STAT6 promoter in HC11 mouse mammary epithelial cells. (B) Luciferase reporter assay in 293T cells showing that E2F5 represses STAT6 promoter activity. (C) STAT6 promoter-luciferase reporter assay of MCF7 cells treated with vehicle or R5020 and co-transfected with CMV-HA-E2F5 or CMV-Neo-Bam (empty vector).

    Article Snippet: For CUT&RUN, rabbit IgG (Epicypher #13-0042; RRID:AB_2923178), rabbit monoclonal anti-H3K27me3 (Invitrogen #MA5-11198; RRID:AB_1100074), rabbit monoclonal anti-H3K4me3 (Epicypher #13-0041; RRID:AB_3076423), and rabbit polyclonal anti-E2F5 (Invitrogen #PA585578; RRID:AB_2792718) were used at 0.5 ug per sample replicate in 50 uL of volume.

    Techniques: Luciferase, Reporter Assay, Activity Assay, Transfection, Plasmid Preparation

    In the absence of progesterone signaling, E2F5 binds to the STAT6 promoter and represses its transcription (left panel). Upon activation of PR, E2F5-mediated repression is relieved, leading to transcriptional activation of STAT6. This could occur either by displacement of E2F5 from the STAT6 promoter or through cooperation between E2F5 and activated PR at the STAT6 promoter (right panel).

    Journal: bioRxiv

    Article Title: Transcriptional Regulation of Mammary Alveolar Proliferation and Differentiation during Early Pregnancy

    doi: 10.1101/2024.11.27.625731

    Figure Lengend Snippet: In the absence of progesterone signaling, E2F5 binds to the STAT6 promoter and represses its transcription (left panel). Upon activation of PR, E2F5-mediated repression is relieved, leading to transcriptional activation of STAT6. This could occur either by displacement of E2F5 from the STAT6 promoter or through cooperation between E2F5 and activated PR at the STAT6 promoter (right panel).

    Article Snippet: For CUT&RUN, rabbit IgG (Epicypher #13-0042; RRID:AB_2923178), rabbit monoclonal anti-H3K27me3 (Invitrogen #MA5-11198; RRID:AB_1100074), rabbit monoclonal anti-H3K4me3 (Epicypher #13-0041; RRID:AB_3076423), and rabbit polyclonal anti-E2F5 (Invitrogen #PA585578; RRID:AB_2792718) were used at 0.5 ug per sample replicate in 50 uL of volume.

    Techniques: Activation Assay